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Mutations in Cu/Zn superoxide dismutase (Sod1) have been reported
in both familial and sporadic amyotrophic lateral sclerosis (ALS).
In this study, we investigated the behavior of heteromeric combina-
tions of wild-type (WT) and mutant Sod1 proteins A4V, L38V, G93A,
and G93C in human cells. We showed that both WT and mutant
Sod1 formed dimers and oligomers, but only mutant Sod1 accumu-
lated in intracellular inclusions. Coexpression of WT and hSod1
mutants resulted in the formation of a larger number of intracellular
inclusions per cell than that observed in cells coexpressing WT or
mutant hSod1. The number of inclusions was greater in cells
expressing A4V hSod1. To eliminate the contribution of endogenous
Sod1, and better evaluate the effect of ALS-associated mutant
Sod1 expression, we expressed human Sod1 WT and mutants in
human cells knocked down for endogenous Sod1 (Sod1-KD), and in
sod1Δ yeast cells. Using Sod1-KD cells we found that the WT–A4V
heteromers formed higher molecular weight species compared with
A4V and WT homomers. Using the yeast model, in conditions of
chronological aging, we concluded that cells expressing Sod1
heterodimers showed decreased antioxidant activity, increased
oxidative damage, reduced longevity, and oxidative stress-induced
mutant Sod1 aggregation. In addition, we also found that ALS-
associated Sod1 mutations reduced nuclear localization and, con-
sequently, impaired the antioxidant response, suggesting this
change in localization may contribute to disease in familial ALS.
Overall, our study provides insight into the molecular underpin-
nings of ALS and may open avenues for the design of future
therapeutic strategies.
Sod1 | amyotrophic lateral sclerosis | aging | heterodimers
Amyotrophic lateral sclerosis (ALS) is a progressive anddevastating neurological disease characterized by the loss of
motor neurons in the spinal cord, motor cortex, and brainstem
(1). The prevalence of ALS is ∼4 to 7 per 100,000. The etiology is
complex and can present as sporadic (sALS) (90 to 95% of cases),
or familial (fALS) (5 to 10% of cases) (1–3). However, several
gene mutations have been observed in patients with either familial
or sporadic forms of ALS.
Among the fALS cases, 20 to 25% are associated with mutations
in the Cu/Zn isoform of superoxide dismutase (Sod1), encoded by
the SOD1 gene. Sod1 is widely distributed throughout the cell, in-
cluding in the cytoplasm, lysosomes, and the intermembrane space
of mitochondria. More recently, it was also detected in the nucleus,
as a response to oxidative stress (4, 5). Sod1 is responsible for the
dismutation of superoxide anions and, in recent studies, it was as-
sociated with the expression of antioxidant and repair genes (5).
Indeed, fALS-associated Sod1 mutations were initially thought to
lead to a loss of dismutase function (6, 7). However, a toxic gain of
Sod1 function may also contribute to disease, since SOD1 knockout
animals do not exhibit ALS-like phenotypes (4). Importantly, fALS
is primarily a heterozygous genetic condition and over 150 mutations
have been identified in human Sod1 (hSod1) (8). Nevertheless,
despite extensive research, the underlying causes of ALS and the
paths of neurodegeneration remain elusive.
We recently showed that expression of fALS hSod1 mutant
(A4V, L38V, G93A, and G93C) homodimers results in increased
hSod1 aggregation, in intracellular oxidation, and in genomic
instability due to the hSod1 mislocalization, when compared to
the expression of WT hSod1 (9). Several studies showed that
coexpression of human WT and mutant Sod1 accelerates disease
in transgenic animals (10–12). In this context, it has been pro-
posed that WT Sod1 (human or mouse) may slow mutant Sod1
aggregation (13, 14). In addition, the formation of WT and mutant
heterodimers might modulate Sod1 aggregation, which seems to
be stabilized by the presence of WT protein (15, 16). Although
most fALS studies have focused on the investigation of Sod1
homodimers/homomers, the investigation of Sod1 heterodimers/
heteromers remains controversial, and poorly explored. Altogether
our study provides insight into the molecular effects of both Sod1
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homo- and heterodimers, establishing the basis for future studies that
may impact on our understanding of the molecular underpinnings
of ALS.
Results
Coaggregation of WT and fALS-Associated Mutant hSod1 Heterodimers
in Human Cells. In order to assess the aggregation of WT and
mutant human Sod1 heteromers, we used the bimolecular fluo-
rescence complementation (BiFC) assay (9, 17). In this assay,
fluorescence requires the interaction between at least 2 proteins,
each of which is fused to nonfluorescent, truncated fragments of a
fluorescent protein (e.g., Venus fluorescent protein) (Fig. 1A). Thus,
the BiFC assay enables the study of homo- or heterodimeric pro-
tein species, which may then assemble into higher order oligomers
(homomers or heteromers). We found that all heteromeric WT
hSod1 and mutant hSod1 combinations formed dimers/oligomers
and inclusions (Fig. 1 B and C). In cells expressing WT hSod1
BiFC pairs, no inclusions were detected (Fig. 1C). Although the
inclusions formed by the different mutants showed similar sizes
and shapes, the number of inclusions per cell was variable (Fig.
1C). Approximately 60% of the cells expressing hSod1 A4V dis-
played inclusions, while around 20% of cells expressing other
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Fig. 1. Mutations affect Sod1 distribution and inclusion formation in human cell model. (A) Schematic representation of the BiFC assay. In the case of
heterodimers, WT hSod1 was fused to C-terminal of VN fragment (VN–WT Sod1) and mutant hSod1 was tagged to N-terminal of VC fragment of Venus
fluorescent protein (mutant Sod1–VC). To obtain WT hSod1 homodimers, cells contained WT Sod1–VC instead of mutant Sod1–VC. (B) Representative pictures
of cells expressing fALS-related hSod1 mutant heterodimers. H4 cells expressing WT (VN–Sod1) and mutant hSod1 (Sod1–VC) (A4V, L38V, G93A, and G93C)
were analyzed by fluorescence microscopy. Some hSod1 aggregates are pointed out by white arrows. (Scale bar: 10 μm.) (C) Quantification of the number of
inclusions per cell. At least 50 cells were counted per condition and classified in 3 different groups: blue, purple, and yellow bars represent the percentage of
cells without any inclusion, with 5 or less inclusions and cells with more than 5 inclusions, respectively. Data were combined from at least 3 independent
experiments. (D) Representative immunoblot confirming expression of VN–Sod1 and Sod1–VC fragments in H4 cells. (E) Quantification of the immunoblots.
Data are expressed as mean ± SD of at least 3 replicates. One-way ANOVA, with Bonferroni correction, was used for statistical analysis with significance level
of *P < 0.05, which represents statistically different results between mutant hSod1 with the WT hSod1 variant (mutSod1 vs. WTSod1).
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mutant hSod1 proteins displayed inclusions. In addition, the number
of inclusions per cell was also different, with A4V forming more
inclusions (>5 inclusions) than the other mutants. The levels of
A4V and L38V mutants were identical, except those of G93A and
G93C, suggesting these mutants may be more unstable in the
cellular environment (Fig. 1 D and E).
The A4V Mutation Affects the Intracellular Dynamics of hSod1. Next,
we assessed the dynamics of fALS-related Sod1 heteromeric in-
clusions using fluorescence recovery after photobleaching (FRAP).
Prebleaching images were captured to estimate the initial fluores-
cence intensity, and the recovery after bleaching was analyzed
(Fig. 2). We found that A4V inclusions exhibited the longest half-
recovery time (24.91 ± 4.90), while inclusions formed by the other
mutants exhibited similar values (L38V: 4.71 ± 1.00; G93A: 4.07 ±
1.08; G93C: 5.26 ± 1.80) (Fig. 2B). This indicates that A4V inclu-
sions are less labile than those formed by L38V, G93A, or G93C
fALS variants.
Sod1 WT–A4V Heterodimers Aggregate into Higher Molecular Weight
Species. The BiFC assay relies on the formation of, at least,
protein dimers. However, given the nature of the assay, it does
not inform on whether nonfluorescent dimers may also accu-
mulate in the same cells (e.g., dimers of Sod1–N-terminal re-
gion of Venus [VN] or of Sod1–C-terminal region of Venus
[VC]). Thus, in order to investigate the types of species formed,
we used human cells deficient (knocked down [KD]) in endog-
enous Sod1 (Sod1-KD), generated using CRISPR/Cas9 tech-
nology (SI Appendix, Figs. S1 and S2), and expressed the Sod1–
VN and Sod1–VC constructs, as described above. Given the
more robust findings with the WT–A4V pair, we focused on
this mutant and performed immunocytochemistry (ICC) using
antibodies against either Sod1 or an anti-GFP antibody that
recognizes only the VC (SI Appendix, Fig. S3), in order to detect
only 1 of the constructs. Using this approach, we distinguished the
population of dimers formed by the complementation between
VN and VC fragments (detected by the Venus signal), from
either the total pool of Sod1 or from the pool of Sod1–VC
(recognized by an anti-GFP antibody) (Fig. 3 A–C). The overlap
in BiFC signal with those detected upon immunostaining with
either Sod1 or GFP antibodies confirmed that the majority of
species formed by WT–WT (Fig. 3A), A4V–A4V (Fig. 3B), or
WT–A4V (Fig. 3C) were detected by the BiFC assay, suggesting
other types of dimers were absent, or were at least negligible.
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Fig. 2. Interaction dynamics of mutant Sod1 heterodimers in H4 cells. (A) In the Upper part, schematic illustration of FRAP of an inclusion of interest. At the
Bottom, from left to right: a panel with 3 images of a representative cell expressing the heterodimer inclusion before photobleaching, just after photobleaching,
and at the end of image acquisition. (B) FRAP recovery curves for heterodimers inclusions of VN–WT and mutant Sod1–VC. For each mutation, at least 6 inclusions
in different cells were analyzed. Each plot represents mean ± SD for each time point for all FRAP experiments.
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This finding is important as it demonstrates that the major pop-
ulation of dimers detected in the WT–A4V combination are,
indeed, heterodimers.
Next, in order to compare the oligomerization state of hSod1,
we separated total cell extracts using size-exclusion chromatog-
raphy (SEC) (SI Appendix, Fig. S4) and assessed the presence of
hSod1 in the fractions using dot blotting (Fig. 3 D–G). Consistently
with the microscopy results (Fig. 1), we found that WT–A4V hSod1
heteromers (Fig. 3G) formed higher molecular weight species
than WT hSod1 homomers (Fig. 3E). We did not find inclusions
in cells expressing WT hSod1 homomers (Fig. 1). Strikingly,
WT–A4V heteromers formed even higher molecular weight spe-
cies (Fig. 3G) than A4V homomers (Fig. 3F). Interestingly, we did
not detect hSod1 in fractions C1–C8 (44 to 17 kDa), which might
be expected to contain monomeric hSod1. This suggests that hSod1
heteromers, and not monomers, assemble into higher molecular
weight species.
Mutant hSod1 Heterodimers Display Reduced Dismutase Activity in
Chronologically Aged Yeast Cells When Compared to Homodimers.
Yeast cells are ideally suited living test tubes for investigating the
effect of oxidative stress on the molecular mechanisms associ-
ated with neurodegenerative diseases (18). Exponentially grow-
ing yeast cells obtain energy by fermentation and, consequently,
produce low levels of reactive oxygen species (ROS), which in-
crease in chronologically aged cells (18, 19). To investigate the
functionality of the WT and mutant Sod1 heterodimers, we used
sod1Δ yeast cells expressing WT or mutant hSod1–VN together
with mutant hSod1–VC, to evaluate the effect of the hSod1 ex-
pression in the absence of endogenous yeast Sod1 (ySod1) activity.
First, we confirmed the expression of hSod1 fused to either VN or
VC fragments of Venus using an antibody against hSod1 (Fig. 4A),
both before and after chronological aging. Next, we investigated
the effect of chronological aging on mutant hSod1 activity. Aging,
per se, did not alter WT hSod1 activity. However, sod1Δ cells
expressing mutant A4V, G93A, or G93C homodimers, showed a
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Fig. 3. hSod1 WT–A4V heterodimers aggregate into higher molecular weight species. HEK293 Sod1-KD cells were transfected with plasmids encoding the
different hSod1 constructs (VN and VC fusions) and imaged using confocal microscopy (A–C). Each panel shows the fluorescence intensities of the BiFC signal
counterstained with antibodies against Sod1 or GFP. The anti-GFP antibody used recognizes only the C-terminal fragment of Venus (VC). Sod1-KD cells
expressing the homodimer hSod1–WT (A), the homodimer hSod1–A4V (B), and the heterodimer hSod1–WT–A4V (C). SEC followed by dot blot analysis using
an anti-hSod1 antibody (D–G). SEC results are representative from at 3 independent experiments. Dot blot from Sod1-KD cells transfected with pcDNA3.1 (D),
with WT–Sod1 BiFC constructs (E), with the A4V–Sod1 constructs (F), or with the WT–A4V–Sod1 constructs (G).
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significant increase in dismutase activity upon aging (Fig. 4B).
Interestingly, activity of A4V, G93A, or G93C mutant hSod1
heterodimers was decreased when compared with the homodimer
counterparts and with WT Sod1 relative activity. Aging did not
alter L38V Sod1 activity, neither homo- nor heterodimers.
To determine whether we were measuring only hSod1 activity of
heterodimers, or if the homodimers (WT or A4V, as an example)
were also present, we used yeast cells expressing Sod1 fused with
only 1 of the fragments of Venus. Consistently with the observa-
tions in human cells, which showed no detectable hSod1 monomers
or homodimers in cells expressing WT–A4V hSod1 (Fig. 3G), we
found no hSod1 activity (i.e., dimerization) in cells expressing either
VN- or VC-tagged hSod1 (Fig. 4C), suggesting, once again, that the
dominant form of the hSod1 species formed upon coexpression of
WT and mutant hSod1 was heteromeric/heterodimeric.
hSod1 Heterodimers Are Not Able to Increase Longevity of sod1Δ Yeast
Cells and to Protect Against Oxidative Damage. To investigate whether
the differences in activity between hSod1 homo- and heterodimers
affected yeast cells longevity, we determined the survival rates after
chronological aging. We found that 44.9% of sod1Δ cells remained
viable upon aging (Fig. 5). Overexpression of WT hSod1 in a sod1Δ
background considerably increased the cellular viability to 90%,
confirming the functional overlap between the yeast and human
proteins. Strikingly, cells expressing WT–mutant Sod1 heterodimers
displayed reduced viability when compared to cells expressing
the individual homodimers, suggesting that the heterodimers are
functionally impaired.
Aged cells show increased oxidative damage levels, which can
be reversed by an effective antioxidant system. Consistent with this,
expression of WT hSod1 in sod1Δ yeast reduced the damage caused
by aging (Fig. 6). Confirming hSod1 heterodimer dysfunction, we
found that cells expressing mutant hSod1 heterodimers displayed
increased lipid peroxidation (Fig. 6A) and protein carbonylation
(Fig. 6B). Surprisingly, expression of mutant hSod1 homodimers
(A4V, L38V, and G93A) reduced the levels of lipid peroxidation
upon aging. Expression of A4V or G93C hSod1 also reduced
protein carbonylation. This suggests that different hSod1 mutants
may influence the oxidative stress response in different ways, and
that the toxicity associated with the formation of hSod1 heterodimers
may be induced by oxidative modifications occurring in aged
yeast cells.
Aging Induces the Formation of hSod1 Inclusions in Yeast Cells. Next,
we investigated whether oxidative damage caused by chronological
aging affected hSod1 aggregation in cells expressing homodimers
or WT–mutant heterodimers. Exponentially growing sod1Δ cells
expressing hSod1 homo- or heterodimers displayed no visible in-
clusions (Fig. 7A). In contrast, chronologically aged yeast cells
expressing homo- or WT–mutant heterodimers accumulated
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Fig. 4. Superoxide dismutase activity of hSod1 homo- and heteromers. (A)
Representative immunoblot confirming expression of VN–Sod1 and Sod1–VC
fragments in yeast cells, both before and after aging conditions. (B) Superoxide
dismutase activity was performed in exponential-phase sod1Δ cells expressing
the hSod1, before and after chronological aging. Values are means ± SD of at
least 3 independent experiments and represent the ratio of hSod1 activity be-
tween aged and nonaged yeast cells. * represents statistically different results
between mutant hSod1 with the WT hSod1 variant (mutSod1 vs. WTSod1).
Colored bars represent mutant homodimers, and hatched colored bars repre-
sent mutant heterodimers. (C) Sod1 activity of yeast sod1Δ cells expressing only
the hSod1 VN or only presenting the VC fragment, in WT or A4V hSod1. Sod
activity was performed in exponential-phase cells before chronological aging.
Fig. 5. Expression of WT–mutant heteromers decreases cellular viability after
24 h aging. Yeast cell lacking endogenous Sod1 (sod1Δ) as well as carrying
hSod1 (WT and mutants) were harvested at exponential phase and aged in
water (nonproliferating condition) at 37 °C for 24 h. Cellular viability was
carried out by counting plated cells on dropout 2% and expressed as the
percentage of viable cells. Hatched and nonhatched colored bars represent
mutant heterodimers and homodimers, respectively. The results represent the
mean ± SD of at least 3 independent experiments. * represents statistically
different results between sod1Δ or hSod1 mutants with the WT hSod1 variant
(sod1Δ or mutants Sod1 vs. WT Sod1). ** statistically different results between
recombinant yeast cells expressing hSod1 with the respective nonrecombinant
strain, sod1Δ (WT or mutants hSod1 vs. sod1Δ).
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cytosolic inclusions, suggesting that oxidative stress increases
the aggregation of fALS hSod1. We found that ∼50% of aged yeast
cells expressing hSod1 A4V homodimers displayed multiple inclu-
sions, while the percentage of cells with inclusions was lower than
40% in cells expressing the other hSod1 mutants (Fig. 7B). Cells
expressing WT and A4V, L38V, G93A, or G93C heterodimers
displayed a larger number of inclusions per cell. Moreover, the
percentage of cells with hSod1 inclusions significantly increased to
∼80 in cells expressing WT–A4V heterodimers. In cells expressing
the other homodimers or WT–mutant heterodimers, the percentage
of cells with inclusions was between ∼30% and ∼50%.
As it can be seen in Fig. 8A, we found that WT hSod1 is lo-
calized in nucleus after the aging process. However, while ∼80%
of the cells expressing WT hSod1 showed hSod1 in the nucleus,
the percentage of cells displaying nuclear localization of hSod1
dropped to less than 4% in cells expressing WT–mutant hSod1
heterodimers (Fig. 8B). To investigate whether the presence
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Fig. 6. The heterodimerization of WT and fALS mutant hSod1 significantly
increases oxidative stress markers in chronologically aged yeast cells. Lipid
peroxidation (A) and protein carbonylation (B) were determined in sod1Δ
recombinant cells expressing WT hSod1 or mutant homo- and heterodimers,
before and after aging. Mutant heterodimers are represented by hatched bars
on the Left side. (A) The lipid peroxidation levels were expressed in pMoles of
MDA/mg of cells. As a control, the levels of MDA of nonaged cells (soft
colored bars) of all recombinant strains and the nonrecombinant strain
sod1Δ were determined. The results carried out after aging are represented
by dark colored bars. * represents statistically different results between
nonaged mutant homo- and heterodimers with the nonaged WT hSod1
variant (mutant Sod1 vs. WTSod1), or aged mutants with aged hSod1WT. (B)
Fold increase in protein carbonylation was measured as a ratio between
protein carbonyl contents detected in aged yeast cells and the levels pre-
sented in nonaged yeast cells. The results represent the mean ± SD of at least
3 independent experiments. * represents statistically different results be-
tween mutant homo- or heterodimers with the WT hSod1 (sod1Δ or mutant
hSod1 vs. WT hSod1).
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Fig. 7. Chronological aging induces the formation of mutant hSod1 cytoplasmic
inclusions. (A) Representative pictures showing the localization of BiFC–
hSod1 mutants in yeast cells imaged by fluorescence microscopy, both be-
fore and after aging. Arrows indicate some hSod1 inclusions. (Scale bar:
10 μm.) (B) Quantification of the number of inclusions per cell. At least
50 cells were counted per condition and organized in 3 different categories
which represent: the percentage of cells without any inclusion (blue bar),
with 5 or less inclusions (purple bar), and yeast cells with more than 5 in-
clusions (yellow bars). One-way ANOVA, with Bonferroni correction, was
used for statistical analysis with significance level of ***P < 0.001 (WT vs.
mutant cells). **P < 0.01 shows the significance level between WT and
mutant cells. Data were combined from at least 3 independent experiments.
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hSod1 in the nucleus is important to the antioxidant response, we
measured catalase (Ctt1) activity in aged and dividing yeast cells.
Ctt1 activity increased 3-fold after aging in the BY4741 control
strain, expressing endogenous yeast Sod1 (Fig. 8C). The re-
placement of yeast Sod1 by WT hSod1 doubled Ctt1 activity in
aged cells, suggesting that the nuclear hSod1 promoted the in-
duction of genes involved in ROS resistance, including CTT1. In
contrast, sod1Δ yeast cells expressing WT–mutant hSod1 hetero-
dimers showed no or a lower increase in Ctt1 activity after aging
when compared to sod1Δ WT hSod1. Taken together these re-
sults suggest that the cytosolic formation of WT–mutant hSod1
inclusions impairs the translocation of functional protein into the
nucleus, compromising the antioxidant cell response and, con-
sequently, cell longevity.
Discussion
Here, we investigated the formation of heterodimers/heteromers
between WT and ALS-associated mutant forms of hSod1 in living
cells. The inclusions formed by the heteromeric combination
demonstrated a higher propensity to aggregate into numerous
inclusions per cell when compared to hSod1 mutant homodimers,
as recently showed (9). The increased percentage of cells with
WT–A4V heteromeric inclusions was consistent with the greater
stability of the inclusions (assessed by FRAP) when compared to
the other fALS Sod1 variants. Consistently with the accumulation
of protein inclusions in cells, we found that WT–A4V hSod1
heteromers formed higher molecular weight species than A4V
homomers, as confirmed by SEC analyses. Thus, we hypothesized
that the inclusions formed by WT–mutant hSod1 heterodimers
might be related to the toxicity of fALS-linked hSod1 mutants. In
a previous study also using FRAP to investigate the inclusions
formed by mutants of Fus, Tdp-43, or Sod1–GFP, it was found
that the diffusion properties of Fus and Tdp-43 were significantly
different from those formed by Sod1 A4V, which presented a rapidly
diffusing component (20). In that work, the authors expressed only
the mutant form of hSod1. In contrast, FRAP measurements of
Sod1 A4V heterodimers revealed very slowly diffusing species,
which are consistent with stable inclusions.
By using differential immunostainings with anti-Sod1 and anti-
GFP antibodies, we confirmed that the majority of oligomeric
species formed in the cells could, indeed, be detected by the BiFC
system, suggesting that cells coexpressing WT and A4V mutant
hSod1 accumulate, primarily, heterodimers/heteromers. In sod1Δ
yeast cells, the absence of hSod1 activity in cells expressing only
VN or VC fusions, also confirmed that most hSod1 dimers formed
in cells coexpressing VN and VC fusions resulted from the BiFC
interaction, and that this may be sterically favorable, and perhaps
stabilized by the assay.
Several studies in models of replicative or chronological aging
suggest that the oxidative stress response is impaired and con-
tributes to pathogenesis in fALS (9, 19, 21, 22). Regarding
chronological aging, yeast and human cells, such as neurons,
share several similarities (23–26). Given the remarkable advantages
of yeast as a model for investigating the oxidative stress response
of mutant hSod1, we took advantage of the BiFC system to study
the activity and functionality of WT–mutant hSod1 heterodimers
in chronologically aged yeast cells lacking the endogenous ySod1
(sod1Δ). We found that the activity of mutant hSod1 homodimers
increased upon aging. On the other hand, the formation of
dismutase-active mutant heterodimers was reduced in aged yeast
cells. Although the fALS-associated hSod1 mutations studied here
are considered to behave like the wild-type enzymes (27, 28), the
oxidative stress induced by chronological aging modulates hSod1
activity, revealing a different but bona fide effect of the hSod1
mutant homo- and heterodimers in response to aging. Previously,
it was suggested that dismutase-active WT hSod1 dimers might
contribute to the toxicity caused by the presence of fALS-linked
mutation (16). Indeed, the reduced hSod1 activity of mutant
DAPI MergeSod1 BiFC
After 24h aging
10 μm
A B
C
 

WT - WT
WT - A4V
WT - L38V
WT - G93A
WT - G93C
__________
Fig. 8. hSod1 nuclear localization is impaired by fALS-linked mutations after aging. (A) hSod1 WT and mutant heterodimers were imaged by fluorescence
microscopy after aging. Inclusions of Sod1 were visualized by expression of BiFC-tagged Sod1 (green), and the nucleus was stained by DAPI (blue). Arrows
indicate the colocalization of the hSod1 with the nucleus, induced by the aging process. (Scale bar, 10 μm.) (B) Percentage of cells with prominent
Sod1 nuclear localization. Error bars indicate ±SD of triplicates and at least 50 cells were counted per replicate. One asterisk represents statistically different
results between mutant heterodimers with the WT hSod1 form (BY4741 or mutant hSod1 vs. WT hSod1). (C) Catalase activity results were expressed as a fold
increase in specific activity (U/mg of protein) after chronological aging. One unit (U) of activity is defined as the amount of enzyme that catalyzes the
consumption of 1 μmol H2O2/min under the assay conditions. The results represent the mean ± SD of at least 3 independent experiments. One-way ANOVA,
with Bonferroni correction, was used for statistical analysis with significance level of *P < 0.05 (WT vs. mutant cells or BY4741).
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heterodimers correlated with the survival rates; cells expressing
hSod1 heterodimers showed a decreased percentage of viable
cells after chronological aging, compared to those expressing
hSod1 WT. Otherwise, the highly active WT and mutant hSod1
homodimers increased lifespan considerably compared to sod1Δ,
suggesting that mutant homodimerization provides benefits after
24 h aging. By contrast, the mutant heterodimers, but not homo-
dimers, showed similar viability rates to the sod1Δ control cells.
Neither the wild-type protein nor any of the currently modeled
fALS mutations in yeast induced any severe growth defect (29–34).
Thus, studies in chronologically aged Saccharomyces cerevisiae have
successfully uncovered several aspects underlying the hSod1 ac-
tivity as well as the cellular longevity upon the expression of
hSod1 mutant (homo- and heterodimers) linked to fALS.
In vitro, the rates and free energy of heterodimerization (ΔGHet)
of ALS-associated mutant apo-Sod1 proteins (D90A, G37R,
E100K, E100G, G93R, D101N, and N86D), suggest a possible
correlation between the ΔGHet of each ALS Sod1 variant with
patient survival time after diagnosis (35). The possible mecha-
nisms of heterodimer formation were proposed to initiate from
homodimeric forms, involving the swapping of subunits—the
mutant andWT homodimers would first dissociate into monomers
and then recombine into heterodimers or, alternatively, would
initially associate into oligomers which would then dissociate into
heterodimers (35). The proposed mechanisms did not consider
that heterodimerization may also occur from recently new syn-
thesized monomers (WT and mutant), which could interact and
heterodimerize “de novo.” This de novo heterodimerization
mechanism might also occur in our cell model and might be faster
than the heterodimerization starting from homodimers.
In order to study homodimer association (ka) and dissociation
(kd) constant rates from purified apo-Sod1 monomers, the ex-
perimental analyses were conducted under oxidizing conditions
to keep the intramolecular disulfide linkage between C57 and
C146 intact (36). WT and ALS mutants were produced on a
background C6A/C111A (36), or C6A/C111S (37) in order to
avoid artifacts from nonnative disulfide crosslinks (pseudo-Sod1
[pSod1]). The substitutions C6A/C111A, or C6A/C111S, were
shown not to affect the stability or folding of Sod1 (36–39). The
second-order ka for WT or mutant pSod1 homodimer associa-
tion is in the order of magnitude of 107 M−1 min−1 while the
constant rate of dissociation (kd) of the pSod1 homodimer dis-
sociation and the constant rate of WT–ALS mutant hetero-
dimerization (kHet) are around 10
−2 min−1 (35–38). Although,
there are no data for the constant rate for WT monomer–mutant
monomer association, these analyses are consistent with the de
novo heterodimerization mechanism, since this would be faster
than starting from homodimer precursors.
Although the formation of homodimers is possible, the for-
mation of functional homodimeric Sod1 was not detected in our
system. This might be due to 2 possible explanations: 1) protein
quality-control systems would primarily eliminate less stable
proteins, consistently with studies reporting increased resistance
against proteolytic degradation for mutant Sod1 heterodimers than
for mutant Sod1 homodimers (16); and 2) steric hindrance of the
fusion protein affecting mutant Sod1 homodimerization, which
would have to be further investigated in independent studies.
We observed that the presence of all mutant heterodimers
strongly increased lipid peroxidation. Furthermore, protein car-
bonylation dramatically raised after aging in WT–mutant hSod1
cells, especially for L38V, G93A, and A4V mutants. Our study
establishes that the WT–mutant heterodimerization might actively
contribute to enhance mutant hSod1 toxicity, resulting in cellular
oxidative damages. Using high-resolution mass spectrometry
(MS), high molecular weight (HMW) Sod1 species were found to
be oxidized in residues critical for Sod1 activity (Cys146, His71,
and His120) and stability. In addition, HMW P < 0.01Sod1–GFP
aggregation sharply increased in stationary-phase aged yeast cells,
suggesting that oxidative damage may trigger Sod1 inclusion (40).
In order to investigate the effects of oxidative stress on hSod1
aggregation in aged yeast cells, we assessed aggregation and nu-
clear localization of WT and mutant hSod1 inclusions. We found
that WT or mutant hSod1 did not form inclusions in young
yeast cells harvested at midexponential phase. In contrast, mutant
homo- and heterodimers form visible and multiple inclusions in
chronologically aged cells. This was stronger for WT–A4V
heteromers and suggested that the formation of mutant hSod1
aggregates might be directly related to oxidative damage caused
by aging, affecting hSod1 dismutase activity and cellular via-
bility. In response to elevated levels of ROS, WT hSod1 rapidly
relocates into the nucleus, promoting the regulation of the oxi-
dative stress resistance (5). Indeed, we confirmed that, during
chronological aging, hSod1 relocalizes to the nucleus, efficiently
stimulating cellular defense mechanisms against oxidative stress by
the induction of genes involved in ROS resistance. Nevertheless,
hSod1 mutants remain predominantly cytoplasmic, in inclusions,
impairing the ROS-regulated change in cellular localization of
hSod1. Indeed, H2O2 was reported to be sufficient to promote
Sod1 nuclear localization (5). Since catalase is one of the main
antioxidant proteins involved in H2O2 degradation and ROS re-
sistance, we verified that Ctt1 activity is substantially higher in
hSod1 WT-expressing cells after aging, when compared to that in
cells expressing Sod1 heteromers.
A4V and G93A have been classified as class 1+2 mutations,
which can destabilize the precursor monomers as well as weaken
the dimer interface (8, 36). Interestingly, our data suggest the
absence (or low levels) of monomeric species in Sod1-KD cells
expressing WT–A4V heteromers, and the predominant forma-
tion of heteromeric, rather than homomeric species. Thus, on
the basis of this result, we hypothesize WT hSod1 proteins may
exist primarily as unfolded monomers and become fully active
hSod1 dimers. On the other hand, mutant hSod1 proteins might
exist primarily as unfolded/misfolded monomeric species (Fig.
9A). It has been shown that oligomer formation requires co-
valent disulfide bonds (C6–C111) between Sod1 monomers (38)
that are much more stable than the dimerization interaction. In
the presence of stable WT–mutant heterodimers, the formation
of hSod1 heteromers seems to be initiated by Sod1 heterodimers
due to the stability caused by the interaction with a WT folded
monomer (Fig. 9B). Indeed, by observing an increase in re-
sistance against proteolytic degradation, WT hSod1 stabilizes
the folding of heterodimers compared to mutant homodimers
(16). Hence, considering that WT hSod1 stabilizes mutant vari-
ants by heterodimerization as well as the inefficient heterodimer
response against oxidative conditions, we hypothesize that mutant
heterodimers may contribute to fALS-linked mutant hSod1 toxicity
under aging conditions, opening avenues for the understanding
Fig. 9. Model for the formation and effects of WT–mutant hSod1 heteromers.
(A) The folding and assembly of hSod1 WT into dimeric species. (B) The
formation of Sod1 heteromers, which seems to be related to oxidative stress,
possibly starts from hSod1 heterodimers species, and not fromWT or mutant
hSod1 monomers.
8 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.1902483116 de Araújo Brasil et al.
D
ow
nl
oa
de
d 
at
 N
ie
de
rs
ae
ch
sis
ch
e 
St
aa
ts
- u
nd
 U
ni
ve
rs
ita
et
sb
ib
lio
th
ek
 G
oe
tti
ng
en
 o
n 
De
ce
m
be
r 6
, 2
01
9 
of the molecular mechanisms associated with mutant hSod1
toxicity.
Materials and Methods
Human Cell Culture and Transfections.Human neuroglioma cells (H4) as well as
human embryonic kidney 293 cells (HEK293) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Life Technologies, Invitrogen), supple-
mented with 10% (vol/vol) fetal bovine serum (FBS) and 1% (vol/vol) peni-
cillin–streptomycin, at 37 °C, and 5%CO2 humidified atmosphere. Transfections
in H4 cells were performed by the calcium phosphate method, and
HEK293 cells were transfected, 24 h after plating, with Metafectene (Biontex
Laboratories GmbH) according to the manufacturer’s instructions. Equal
amounts of plasmids encoding theWT ormutant (A4V, L38V, G93A, and G93C)
hSod1 fused to the Venus–BiFC system were used for transfections. The cells
were harvested 48 h posttransfection (9). WT hSOD1 cDNA was cloned to the
3′ end of the VN fragment (VN–WT SOD1), while mutant hSOD1 cDNA was
cloned upstream of the VC fragment (mutant SOD1–VC). The cDNA sequence
of WT hSOD1 and hSOD1 mutants (coding for hSod1 A4V, L38V, G93A, or
G93C) were subcloned from the yeast plasmid YEp351 into the Venus–BiFC
plasmids, as previously described (9, 41).
CRISPR/Cas9-Mediated Sod1-KD. HEK293 cells were transiently transfected
with the “all in one” vector PX459, expressing the guide RNA (gRNA) targeting
5′-GTGTGCGTGCTGAAGGGCGA-3′ sequence in exon 1 of the hSOD1 gene
using Metafectene according to the manufacturer’s instructions. pSpCas9(BB)-
2A-Puro (PX459) V2.0 (Addgene plasmid #62988; http://www.addgene.org/
62988/; RRID:Addgene_62988). After 48 h, cells were selected using 2 μg/mL
puromycin (P11-0-19, PAA Laboratories) for 48 h. Cells were plated on 10-cm
Petri dishes at a density of 1 cell/cm2 and grown until they formed distinct
colonies. Part of each colony was used to extract DNA, followed by sequencing
of exon 1 of the SOD1 gene. Successfully edited colonies were further grown
for subsequent experiments.
Yeast Strains, Yeast Transformation, and Growth Conditions. Human SOD1
cDNA (WT, A4V, L38V, G93A, and G93C) under the control of Sod1 promoter,
were fused to the 3′ end of the N-terminal (VN) or upstream of the C-terminal
(VC) part of Venus (VN–SOD1, SOD1–VC) (42). These sequences were cloned
into the SacI and HindIII sites of pRS425-pME2794 and pME2795 plasmids. The
WT strain BY4741 (MATa; his3, leu2, met15; ura3) and its isogenic mutant
sod1Δ (SOD1::KanMX4), were acquired from Euroscarf. Stocks of all strains
were maintained on solid dropout 2% medium (2% glucose, 0.67% yeast ni-
trogen base without amino acids, 0.2% of dropout mixture, 2% agar). For all
experiments, cells were grown up tomidexponential phase (∼1mg dry weight/mL)
in liquid dropout 2% medium with or without leucine and uracil, at 28 °C
and 160 rpm, with the ratio/flask volume medium of 5:1. While for homo-
dimers construction yeast cells were transformed using pME2794 plasmid (VN)
and pME2795 (VC), containing either 1 copy of WT–VC and WT–VN or mutant
human SOD1–VC and mutant human SOD1–VN, to construct heterodimers,
yeast cells were transformed using the same plasmids, but containing WT–VN
and mutant human SOD1–VC. Transformation of the cells was performed by
electroporation method (43) and then selected by plating on solid dropout 2%
medium without leucine and uracil.
BiFC Plasmids. As previously described (9, 44), the Venus–BiFC plasmids were
subcloned with the cDNA sequence of human WT SOD1 and the mutants
A4V, L38V, G93A, and G93C. This cDNA sequence was obtained from the
yeast plasmid YEp351.
Quantification of hSod1 Inclusions. After transfection (48 h), Dulbecco’s PBS
(DPBS) was used to wash H4 cells. Then, the cells were fixed with 4% para-
formaldehyde (PFA) for 10 min at room temperature (RT), and washed 3 times
with DPBS. For fluorescence microscopy, H4 cells were stained with Hoechst
33258 (Life Technologies, Invitrogen) (1:5,000 in DPBS) for 5 min. A Leica DMI
6000B microscope was used for fluorescence images acquisition (9).
For yeast cell analysis, an aliquot of yeast culture (1mLof suspension 1mg/mL)
was centrifuged and resuspended in 200 μL of distilled water. A total of
1 μL of this suspension, added with 1 μL of n-propyl gallate and 1 μL of 4′-6-
diamino-2-phenylindole (DAPI) (1:10,000 vol/vol) (Sigma-Aldrich), was added
in a slide and maintained in dark for fluorescence microscopy. Fluorescence
images were acquired with an Olympus IX73 microscope. For each result, at
least 50 transfected cells per strain and condition were detected, scored
based on hSod1 inclusions pattern, and classified into 3 groups: cells without
inclusions, 5 or less inclusions (≤5 inclusions), and more than 5 inclusions
(>5 inclusions) (9, 44).
FRAP. FRAP experiments were performed in H4 cells using a Leica 6000B
microscope equippedwith a large incubatormaintained at 37 °C, 5%CO2. Images
were acquired at intervals of 10 s. In each FRAP experiment, hSod1 inclusions
were bleached using a 488-nm laser line at 100% laser transmission on a circular
region of interest. Images were acquired using Metamorph software (Omicron
Laserage) and image processing as well as fluorescence intensity measurements
performed by using ImageJ software (42, 45).
Immunocytochemistry. Immunocytochemistry was performed according to
Guerreiro et al. (46). H4 cells were washed with PBS and fixed with para-
formaldehyde solution 4% in PBS, 48 h posttransfection. The solution con-
taining PBS 0.1% Triton X-100 was used to permeabilize the cells, followed
by a blocking step for 1 h with 1.5% BSA and an overnight incubation of the
primary antibody for anti-Sod1 (Santa Cruz Biotechnology), 1:1,000, and
anti-GFP (B-2, Santa Cruz Biotechnology), 1:1,000. After 3 washes with PBS,
the secondary antibody anti-goat or anti-mouse IgG conjugated to Alexa
Fluor 555 (A31570, Invitrogen, Thermo Fisher Scientific) 1:1,000 was in-
cubated at RT for 1 h. DAPI staining (6355.1, Roth; 0.5 μg/mL) was used to
assess the cell nuclei. Fluorescent confocal images were captured using a
Leica Microsystems microscope (Leica SP5).
Fractionation of Total Protein Extracts by SEC and Dot Blot. As previously
described (46), 48 h posttransfection, Sod1-KD cells were harvested by cen-
trifugation (10 min at 5 °C and 10,000 × g) in a phosphate buffer (TBS with
0.5% Triton X-100) containing protease inhibitor mixture (Roche). By using a
0.45-μm Spin-X centrifuge filter (Sigma), 1.5 mg of total protein in a final
volume of 500 μL was filtered, and subsequently loaded on a Superose 6
(10/300 GL, GE Healthcare Life Science) column. After this, a HPLCy (HPLC)
(Äkta Purifier10, GE Healthcare Life Science) was performed in ammonium
acetate buffer (50 mM, pH 7.4) with a flow rate of 0.5 mL/min. SEC fractions
of 500 μL were collected, boiled at 95 °C for 10 min, and centrifuged at
14,000 × g, 5 °C for 5 min. Then, the collected fractions were probed for
hSod1 using immunodot assay.
Immunoblotting. Total protein extracts were obtained from 48-h transfected
H4 cells, by lysis with radioimmunoprecipitation assay (RIPA) buffer, and
fractionated in 15% SDS/PAGE, as described before (9). The same protocol
was also followed for the running and transference of the gels, which,
thereafter, were incubated with primary antibody 1:2,000 anti-hSod1 and
mouse 1:5,000 anti–γ-tubulin overnight at 4 °C. Then, membranes were in-
cubated for 1 h with anti-goat IgG and anti-mouse secondary antibodies
conjugated to horseradish peroxidase at 1:6,000.
Yeast protein extracts were also fractionated by SDS/PAGE, using 15%
polyacrylamide gels as described (19). The same protocol was also followed
for the running and transference of the gels. The membranes were in-
cubated for 2 h with a rabbit anti-hSod1 and further for 2 h with anti-rabbit
IgG conjugated to horseradish peroxidase. Detection was carried out using
luminol reagent and peroxide solution (Millipore). The band intensity was
estimated using ImageJ software.
Chronological Aging of Yeast Cells. Midexponential phase yeast cells were
centrifuged at 2,500 × g for 5 min and washed twice with distilled water. Cell
pellets were resuspended in water and incubated at 37 °C, 160 rpm, during 24 h
(19). Aged cells were harvested, and the experiments performed accordingly.
Evaluation of Yeast Longevity and Oxidative Damage. Cell viability before and
after chronological aging was analyzed by plating in triplicate on solidified
dropout 2% medium after proper dilution. The plates had been incubated at
28 °C for 72 h, and the colonies were counted. Viability was determined before
and after growth (47–49). Malondialdehyde, a final product of lipid perox-
idation, was measured by thiobarbituric acid reactive species (TBARS) method
(50). Protein carbonylation, used as a biomarker of protein oxidation, was
assayed by slot blot by using a primary anti-DNP (dinitrophenyl) (D9656, Sigma-
Aldrich Merck) followed by incubation with a secondary antibody anti-rabbit
IgG conjugated with peroxidase (A0545, Sigma-Aldrich Merck) (19, 51).
Superoxide Dismutase and Catalase Activity. Extracts for enzymatic determi-
nations were obtained by the disruption of yeast cells (50 mg) with 1.5 g of
glass beads in 50 mM sodium phosphate buffer pH 7.8, containing a protease
inhibitor mixture (cOmplete, mini, EDTA-free protease mixture inhibitor tablets;
Sigma-Aldrich Merck). Protein concentration was determined according to
Stickland (52) using BSA as standard. Sod1 activity was measured in situ after
native polyacrylamide gel electrophoresis from 80 μg of protein in the presence
of riboflavin and nitroblue tetrazolium (NBT). The activity was determined
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based on the ability of superoxide dismutase to inhibit the reduction of NBT by
superoxide radical (19). Then, polyacrylamide gel electrophoresis was digital-
ized on the EC3 imaging system (UVP Bioimaging Systems), and Sod1 bands
were analyzed, taking into consideration the area density by the use of ImageJ
software. Catalase activity was determined by measuring H2O2 consumption at
240 nm (53).
Statistical Analyses.Data were analyzed using GraphPad Prism 5 software and
expressed asmean values ± SD of at least 3 independent experiments. Statistical
differences were calculated using 1-way and 2-way ANOVA with Bonferroni
correction. Significance was assessed: *P < 0.05, **P < 0.01, and ***P < 0.001.
Data Availability. All data generated or analyzed during this study are in-
cluded in this published article and its supplementary information files.
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